HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 547 filers reported holding HORIZON THERAPEUTICS PUB L in Q1 2023. The put-call ratio across all filers is 3.18 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,251,687 | -47.9% | 105,901 | -53.7% | 0.01% | -42.9% |
| Q2 2023 | $23,517,681 | -67.6% | 228,660 | -65.6% | 0.02% | -69.6% |
| Q1 2023 | $72,546,886 | -44.5% | 664,714 | -42.2% | 0.07% | -46.5% |
| Q4 2022 | $130,782,374 | +33.6% | 1,149,230 | -27.3% | 0.13% | +30.3% |
| Q3 2022 | $97,857,000 | -29.9% | 1,581,148 | -9.6% | 0.10% | -23.8% |
| Q2 2022 | $139,582,000 | -26.2% | 1,750,025 | -2.7% | 0.13% | -8.5% |
| Q1 2022 | $189,218,000 | +9.3% | 1,798,480 | +11.9% | 0.14% | +20.3% |
| Q4 2021 | $173,194,000 | +9.6% | 1,607,221 | +11.4% | 0.12% | +4.4% |
| Q3 2021 | $158,094,000 | +20.2% | 1,443,257 | +2.8% | 0.11% | +24.2% |
| Q2 2021 | $131,472,000 | +35.3% | 1,404,020 | +33.0% | 0.09% | +26.4% |
| Q1 2021 | $97,169,000 | +117.9% | 1,055,724 | +73.2% | 0.07% | +111.8% |
| Q4 2020 | $44,586,000 | – | 609,509 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |